47
Iambic Therapeutics, Inc. raises $27.8M under Reg D
Company raise · Raising · Offering $50M · Sold $27.8M · SAN DIEGO, CA · filed 2026-04-08
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Pete Olson | Executive Officer |
| Shalini Sharp | Director |
| Fred Manby | Executive Officer, Director |
| Evan Rachlin | Director |
| Michael Secora | Executive Officer |
| William Rastetter | Director |
| Neil Josephson | Executive Officer |
| Thomas Miller | Executive Officer, Director |
| Jishnu Bhattacharjee | Director |
| Mary Tagliaferri | Director |
| Kurt von Emster | Director |
| R. Jacob Vogelstein | Director |
| Samit Hirawat | Director |
Signed by Sunny Chang, General Counsel.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.